Multicenter, randomized, double-blind, controlled trial of transcutaneous electrical nerve stimulation for pancreatic cancer related pain

Lihua He, Keping Tan, Xianming Lin, Hui Yi, Xueliang Wang, Jiangsong Zhang, Jietao Lin, Lizhu Lin, Lihua He, Keping Tan, Xianming Lin, Hui Yi, Xueliang Wang, Jiangsong Zhang, Jietao Lin, Lizhu Lin

Abstract

Background: Up to 80% of patients with pancreatic cancer experience abdominal and back pain. Although pharmacologic medications provide some relief, many report inadequate analgesia and adverse effects. Transcutaneous electrical nerve stimulation (TENS) is a non-invasive physical modality and had been widely applied for pain relieving, yet no study has investigated the effectiveness of TENS for pain in pancreatic cancer.

Methods: Eligible patients were randomly assigned in a 1:1 ratio to TENS group or control group. The primary outcome was percentage change of numerous rating scale (NRS) after treatment. Secondary outcomes included percentage change of analgesic medication consumption and effect on constipation and poor appetite.

Results: One hundred seventy-one patients were recruited (84 to control group and 87 to TENS group). NRS in TENS group has been largely decreased 77.9% right after treatment and 27.1% in 2 hours, before applying any analgesic medication, while that in control group was slightly downregulated right after treatment but gave a trend to increase at 1, 2, and 3 hours. When comparing both groups, pain was significantly well controlled without analgesic medication supplement in TENS group at 0 hour (difference in mean percent change in NRS = 50.0 [95% CI, 50-51.4], P < .01) and 3 hours (difference in mean percent change in NRS = 134.0 [95% CI, 130.0-142.7], P < .01) after treatment, and this analgesic effect last to 3 weeks after treatment cycle (difference in mean percent change in NRS = 22.5 [95% CI, 17.6-27.3], P < .01) without increase of analgesic medication consumption.

Conclusions: TENS reduces pain without increase analgesic medication consumption in patients with pancreatic cancer pain. It provides an alternative therapy for pain in pancreatic cancer.

Clinical trial registration: This study was registered at ClinicalTrials.gov, identifier NCT03331055.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Figures

Figure 1
Figure 1
CONSORT diagram.
Figure 2
Figure 2
(A) Percent change of abdominal pain scores after each intervention. (B) Percent change of abdominal pain scores after treatment cycle.
Figure 3
Figure 3
Percent change of morphine equivalent consumption.

References

    1. Arcidiacono PG, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev 2011;2011:CD007519.
    1. Beck SL, Towsley GL, Berry PH, et al. Core aspects of satisfaction with pain management: cancer patients’ perspectives. J Pain Symptom Manage 2010;39:100–15.
    1. Turk DC, Dworkin RH, Burke LB, et al. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 2006;125:208–15.
    1. Nagels W, Pease N, Bekkering G, et al. Celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med 2013;14:1140–63.
    1. Jeffrey L, Amitabh G. The use of transcutaneous electrical nerve stimulation (TENS) in a major cancer center for the treatment of severe cancer-related pain and associated disability. Pain Med 2015;16:1204–10.
    1. Lison JF, Amer-Cuenca JJ, Piquer-Marti S, et al. Transcutaneous nerve stimulation for pain relief during office hysteroscopy: a randomized controlled trial. Obstet Gynecol 2017;129:363–70.
    1. Johnson MI, Paley CA, Howe TE, et al. Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database Syst Rev 2015;(6):CD006142.
    1. Gibson W, Wand BM, O’Connell NE. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database Syst Rev 2017;9:CD011976.
    1. Bennett MI, Johnson MI, Brown SR, et al. Feasibility study of transcutaneous electrical nerve stimulation (TENS) for cancer bone pain. J Pain 2010;11:351–9.
    1. Rakel BA, Zimmerman MB, Geasland K, et al. Transcutaneous electrical nerve stimulation for the control of pain during rehabilitation after total knee arthroplasty: a randomized, blinded, placebo-controlled trial. Pain 2014;155:2599–611.
    1. Inoue T, Takenoshita M, Shibata M, et al. Long-lasting effect of transcutaneous electrical nerve stimulation on the thermal hyperalgesia in the rat model of peripheral neuropathy. J Neurol Sci 2003;211:43–7.
    1. Leem JW, Park ES, Paik KS. Electrophysiological evidence for the antinociceptive effect of transcutaneous electrical stimulation on mechanically evoked responsiveness of dorsal horn neurons in neuropathic rats. Neurosci Lett 1995;192:197–200.
    1. Maeda Y, Lisi TL, Vance CG, et al. Release of GABA and activation of GABA (A) in the spinal cord mediates the effects of TENS in rats. Brain Res 2007;1136:43–50.
    1. Lisi TL, Sluka KA. A new electrochemical HPLC method for analysis of enkephalins and endomorphins. J Neurosci Methods 2006;150:74–9.
    1. Network NCC. NCCN clinical practice guidelines in oncology: adult cancer pain. Opioid Principles, Prescribing, Titration, Maintenance, And Safety 2018;7.
    1. Chen AP, Setser A, Anadkat MJ, et al. Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. J Am Acad Dermatol 2012;67:1025–39.
    1. Meng FF, Feng YH. A pilot study of acupuncture at pain acupoints for cervical cancer pain. Medicine 2018;97:e13736.
    1. Hurlow A, Bennett MI, Robb KA, et al. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev 2012;(6):CD006276.
    1. Robb K, Oxberry SG, Bennett MI, et al. A cochrane systematic review of transcutaneous electrical nerve stimulation for cancer pain. J Pain Symptom Manage 2009;37:746–53.
    1. Zheng YC, Yuan TT, Liu T. Is acupuncture a placebo therapy? Complement Ther Med 2014;22:724–30.
    1. Choi TY, Lee MS, Kim TH, et al. Acupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials. Support Care Cancer 2012;20:1147–58.
    1. Hamza MA, White PF, Ahmed HE, et al. Effect of the frequency of transcutaneous electrical nerve stimulation on the postoperative opioid analgesic requirement and recovery profile. Anesthesiology 1999;91:1232–8.
    1. Chen L, Tang J, White PF, et al. The effect of location of transcutaneous electrical nerve stimulation on postoperative opioid analgesic requirement: acupoint versus nonacupoint stimulation. Anesth Analg 1998;87:1129–34.
    1. Han JS, Chen XH, Sun SL, et al. Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain 1991;47:295–8.
    1. Bergeron-Vezina K, Corriveau H, Martel M, et al. High- and low-frequency transcutaneous electrical nerve stimulation does not reduce experimental pain in elderly individuals. Pain 2015;156:2093–9.
    1. Kuai L, Chen H, Zhang TT, et al. Study on dose–effect relationship of electroacupuncture with different current intensities alleviating tibial cancer pain and inhibition of expression of spinal GFAP in rats. Chin Acupunct Moxibustion 2012;32:331–7.
    1. Zhao TY, Xi Q, Guo Y. Current research status and analysis of electroacupuncture parameters for post-operative pain. Shanghai J Acupunct Moxibustion 2015;5:464–7.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere